Data & Policy Center · Pakistan Regulatory Monitor

What changed in Pakistan

Issuing authority: DRAP
Instrument: Guidelines
Date: 4 Nov 2026
Sectors: Pharmaceuticals & health
Official source: www.dra.gov.pk/news_updates/regulatory_updates/general/guideline-for-lot-release
Listed under: Regulatory updates
Recorded: 4 Nov 2026

Citation

Pakistan Institute for Vision Research and Action (PIVRA), Pakistan Regulatory Monitor, "Guideline for Lot Release of Human Vaccines, Blood Products (Plasma Derivatives Medicinal Products) and Anti-Sera. Ijaz Mustafa General November 4, 2026 Guidelines Guide lines of Human vaccines", entry of 4 Nov 2026, https://business.pivra.org/what-changed/4cb86cdd8f40c307.

The title and date are reproduced as published by the issuing authority. This entry is provided for reference and does not constitute legal, tax or investment advice; the official text prevails.

Analysis and monitoring

From publication to implication

Where a new instrument bears on an investment, a licence or an operation, PIVRA provides written analysis, continuous monitoring and access to specialists. Each engagement is scoped and confirmed in writing before work begins.

Service	Timing	Enquire
Analysis of an instrumentA written note on what a regulation, notification or decision changes, to whom it applies, the relevant dates and the steps it requires, with references to the text.	5 to 7 working days	Enquire
Regulatory monitoringA monthly monitoring brief for your sector, covering the sources in this register together with Finance Division, Ministry of Commerce, Ministry of Law, OGRA, PTA, SBP and SECP, and research requests within an agreed allowance.	Monthly	Enquire
Specialist consultationA one-hour call with a Pakistani specialist on a regulatory or policy development, followed by a written summary note.	One hour	Enquire

Discuss a regulatory development

Tell us which publication concerns you and how it relates to your operations. We reply within two business days with a proposed scope and a fixed fee.

Request This Service Book a Consultation

Or message us: · WeChat · Email